Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1622 1625
This examiner grants 80% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17934277 | Methods Of Treating Chronic Kidney Disease (CKD) With Inhibitors Of Protective Loss-Of-Function Genes | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 19322058 | NOVEL B0AT1 INHIBITOR | Final Rejection | MITSUBISHI TANABE PHARMA CORPORATION |
| 17249457 | CARBOXAMIDE AND SULFONAMIDE DERIVATIVES USEFUL AS TEAD MODULATORS | Final Rejection | Genentech, Inc. |
| 18558351 | CRYSTAL FORM IV OF ORGANIC ACID SALTS OF MELANOCORTIN RECEPTOR AGONIST COMPOUND, AND PREPARATION METHOD THEREOF | Non-Final OA | LG CHEM, LTD. |
| 18113369 | DIAGNOSIS METHODS, DIAGNOSTIC AGENTS, AND THERAPEUTIC AGENTS AGAINST ALZHEIMER'S DISEASE AND FRONTOTEMPORAL LOBAR DEGENERATION, AND SCREENING METHODS FOR THESE AGENTS | Non-Final OA | National University Corporation Tokyo Medical and Dental University |
| 17996732 | PHENYL COMPOUND AND PLANT DISEASE CONTROL METHOD | Non-Final OA | SUMITOMO CHEMICAL COMPANY, LIMITED |
| 18026687 | CYANINE COMPOUND AND PHOTOELECTRIC CONVERSION ELEMENT | Non-Final OA | MITSUBISHI GAS CHEMICAL COMPANY, INC. |
| 17784841 | OPHTHALMIC COMPOSITIONS COMPRISING D2O | Non-Final OA | Sydnexis, Inc. |
| 18194867 | FORMULATIONS AND METHODS FOR IMPROVING AVIAN HEALTH | Non-Final OA | CORNELL UNIVERSITY |
| 18530467 | COMPOUNDS AND METHODS TO SENSITIZE CANCER CELLS TO TYROSINE KINASE INHIBITORS | Non-Final OA | Cedars-Sinai Medical Center |
| 17777910 | TRPM8 MODULATORS | Non-Final OA | Givaudan SA |
| 17998219 | CIRCULAR RNA COMPOSITIONS AND METHODS | Non-Final OA | Orna Therapeutics, Inc. |
| 18269916 | A Tracer Compound and a Preparation Method Thereof | Non-Final OA | Turun Yliopisto |
| 18022869 | EXTRACTION METHOD AND MIXTURE OF SUBSTANCES | Non-Final OA | K.D. PHARMA BEXBACH GMBH |
| 18196567 | ADMINISTRATION OF A PSYCHEDELIC COMPOUND | Non-Final OA | Reset Pharmaceuticals, Inc. |
| 18025797 | ARYL HYDROCARBON RECEPTOR LIGANDS AND THEIR ANALOGUES FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISORDERS | Non-Final OA | THE UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION |
| 18016299 | AQUEOUS PHARMACEUTICAL COMPOSITION COMPRISING A P2Y12 RECEPTOR ANTAGONIST | Non-Final OA | Viatris Asia Pacific Ptd. Ltd. |
| 18007724 | NOVEL SELENO-NSAID ANALOGS AND USES THEREOF | Non-Final OA | Ana Carolina RUBERTE SÁNCHEZ |
| 18007726 | FORMS AND COMPOSITIONS OF A BETA ADRENERGIC AGONIST | Non-Final OA | Curasen Therapeutics, Inc. |
| 17998562 | METHODS OF USING BILE ACIDS TO TREAT VIRAL INFECTIONS | Non-Final OA | HOFFMAN TECHNOLOGIES LLC |
| 17929609 | COMPOSITIONS AND METHODS FOR DIAGNOSING, PREVENTING, AND TREATING AMYOTROPHIC LATERAL SCLEROSIS IN PATIENTS WITH HYPOFUNCTIONAL ANTI-TRYPSIN ACTIVITY | Non-Final OA | Motor Life Sciences, LLC |
| 17904144 | 5-HT3 RECEPTOR MODULATOR, THE CRYSTALLINE FORM, METHODS OF MAKING, AND USE THEREOF | Final Rejection | Dejian XIE |
| 17795670 | FLUORINE-CONTAINING PYRIMIDINE COMPOUND AND PRODUCTION METHOD THEREFOR | Final Rejection | UNIMATEC CO., LTD. |
| 17794390 | PD-1/PD-L1 INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF | Final Rejection | ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. |
| 17769924 | DIRECTED CONJUGATION TECHNOLOGIES | Final Rejection | KLEO PHARMACEUTICALS, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy